Randomized controlled trialHuman

Effect of an alpha-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction

Urology, 2000 Oct 1. Wessells H, Gralnek D, Dorr R and 3 others.

Study type
Randomized controlled trial
Subjects
Human participants (PubMed MeSH: Humans)
Journal
Urology
Published
2000 Oct 1
PubMed
PMID 11018622 ↗
DOI
10.1016/s0090-4295(00)00680-4 ↗

Where PepCue cites this

This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.

Melanotan II →

Indexed under

MeSH terms assigned by the National Library of Medicine.

AdultAgedCross-Over StudiesDouble-Blind MethodErectile DysfunctionHumansMaleMiddle AgedNauseaPain MeasurementPenile ErectionPeptides, Cyclic

Other papers on Melanotan II

Clinical trial · 1998
Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study
Case report · 2012
Melanotan II injection resulting in systemic toxicity and rhabdomyolysis

PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page
Compounds